Matthew Calistri | Vice President, Investor Relations |
Jeff Jonas | Chief Executive Officer |
Mike Cloonan | Chief Business Officer |
Kimi Iguchi | Chief Financial Officer |
Steve Kanes | Chief Medical Officer |
Jim Doherty | Chief Research Officer |
Tazeen Ahmad | Bank of America Merrill Lynch |
Danielle Brill | Piper Jaffray |
Cory Kasimov | J.P. Morgan |
Paul Matteis | Stifel Financial |
Ritu Baral | Cowen and Company |
Andrew Tsai | Jefferies |
Brian Abrahams | RBC Capital Markets |
Laura Chico | Wedbush Securities |
Salveen Richter | Goldman Sachs |
Akash Tewari | Wolfe Research |
Maxwell Skor | Morgan Stanley |
Gary Nachman | BMO Capital Markets |
Sumant Kulkarni | Canaccord Genuity |
Yatin Suneja | Guggenheim Partners |
Jay Olson | Oppenheimer & Co. |
Dane Leone | Raymond James |
Marc Goodman | SVB Leerink |
Douglas Tsao | H.C. Wainwright & Co. LLC |
Good morning. And welcome to Sage Therapeutics Third Quarter 2019 Financial Results Conference Call. Currently, all participants are in a listen-only mode. This call is being webcast live on the Investors & Media section of Sage's website at sagerx.com.
This call is the property of Sage Therapeutics and recording, reproduction, or transmission of this call without the express written consent of Sage Therapeutics is strictly prohibited.